Inventor · disambiguated record
Rijian Wang
Also filed as: WANG RIJIAN
6 granted patents·3 pending applications·34 citations·filing 2012–2022
83Inventor score
Files withPRIMATOPE THERAPEUTICS INC4BETH ISRAEL DEACONESS MEDICAL CT INC3QLB BIOTHERAPEUTICS1REIMANN KEITH A1
Top patents by PatentIndex Score
9 records- 0191US11439706B2Polynucleotides encoding a humanized anti-CD40 antibodyPRIMATOPE THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·4 cites·10 claims
- 0290US10772958B2Humanized anti-CD40 antibodies and methods of administering thereofPRIMATOPE THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·7 cites·26 claims
- 0388US10561728B2Polynucleotides encoding anti-CD40 antibodiesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Feb 18, 2020·4 cites·17 claims
- 0487US9974855B2Humanized anti-CD40 antibodies and methods of administering thereofPRIMATOPE THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·7 cites·24 claims
- 0585US9987356B2Anti-CD40 antibodies and methods of administering thereofREIMANN KEITH A·Filed 2012·Granted Jun 5, 2018·9 cites·34 claims
- 0682US10201608B2Polynucleotides encoding humanized anti-CD40 antibodiesPRIMATOPE THERAPEUTICS INC·Filed 2018·Granted Feb 12, 2019·3 cites·10 claims
- 0772US2020261574A1Anti-cd40 antibodies and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 0872US2022133887A1Anti-cd40 antibodies and uses thereofBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2022·Application pending·0 cites
- 0942US2020392230A1Bispecific anti-cd3 x cd20 antibodies and uses thereofQLB BIOTHERAPEUTICS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rijian Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →